A dissolution study carried out using 250 mg capsules containing unformulated ursodeoxycholic acid showed that physical form greatly affected solubility. The sodium salt of ursodeoxycholic acid was soluble in dissolution media, 97% after 15 min, whereas the pharmaceutically approved free acid reached ...
The oral LD50 in rats is >4600-5000 mg/kg.10,11 It is over 7500 mg/kg for mice.11 Ursodeoxycholic acid (UDCA) is associated with rare hepatotoxicities, such as jaundice, worsening pre-existing liver diseases, and hepatitis.2,3 There have been no reports of accidental or intentional over...
Capsules; Oral; Ursodeoxycholic Acid 250 mg Tablets, Film-Coated; Oral; Ursodeoxycholic Acid 150 mg Tablets, Film-Coated; Oral; Ursodeoxycholic Acid 300 mg Medical categories: Human: Cholagogues, cholelitholytics and hepatic protectors Cholelitholytic agents ...
ursodeoxycholic acid capsules 基本信息 活性成分(中) 熊去氧胆酸 活性成分(英) ursodeoxycholic acid(ursodiol) 全球最高研发状态 上市 中国最高研发状态 上市 原研公司 dr. falk pharma gmbh 中国首次上市年份 / 首次上市国家 / 首次上市年份 / 治疗疾病 / 靶点 作用机制 / atc a05aa02➜a 消化道及代谢➜...
戊戌数据药品标准数据库提供了Ursodeoxycholic Acid Capsules熊去氧胆酸胶囊英国药典标准的查询检索,包括Ursodeoxycholic Acid Capsules熊去氧胆酸胶囊英国药典的版本BP2015页码,以及药典的查询与下载.
1. 熊去氧胆酸胶囊 中国药品注册数据库 ... 滔罗特 TAUROLITE熊去氧胆酸胶囊Ursodeoxycholic Acid Capsules优思弗 Ursofalk ... www.drugfuture.com|基于6个网页 2. 药品名称说明 ... 生产厂国内地址 Otto-Hahn-Strβe 13 D-79395-Neuenburg药品名称说明Ursodeoxycholic Acid Capsules优思弗 Ursofalk ... ...
1. OBJECTIVE: To determine the content of Ursodeoxycholic acid in Ursodeoxycholic acid capsules by RP-HPLC. 目的:建立以反相高效液相色谱法测定熊去氧胆酸胶囊中熊去氧胆酸含量的方法。更多例句>> 2) ursofalk capsule 熊脱氧胆酸胶囊3) ursodeoxycholic acid/theraputic use 熊去氧胆酸胶囊/治疗应用...
Penicillamine is available as tablets and capsules. DOGS AND CATS Copper-associated hepatopathy • 10–15 mg/kg PO q.12 h on an empty stomach. However, if gastrointestinaladverse effectsare experienced, these may be reduced if it is given with food, although absorption may be reduced. Alterna...
Pipeline Prospector delivers free access to a database of drugs under clinical trials which made headlines done for Ursodeoxycholic Acid
目的:观察舒肝化瘀方联合熊去氧胆酸胶囊(UDCA)治疗原发性胆汁性胆管炎(PBC)的临床疗效。方法:将50例PBC患者随机分为治疗组和对照组,每组各25例。对照组给予UDCA治疗,治疗组在对照组的基础上联合舒肝化瘀方治疗。2组疗程均为 48 周,观察2组治疗前后的主要症状、体征及肝功能指标、肝纤维化指标和不良反应发生情况...